News and Trends 12 Oct 2022Agreement signed to advance therapy for autoimmune disease HanAll Biopharma’s licensed partner, Harbour BioMed, has signed an exclusive sublicense agreement with CSPC NBP Pharmaceutical Co., Ltd for an… October 12, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email